Health-related quality of life in long-term survivors with localised prostate cancer by therapy-Results from a population-based study.

Long-term localised PC survivors formerly treated with a combination of RP and RT or with ADT report poorer HRQoL and more symptoms than patients treated with either RP or RT alone.